CACCESE, MARIO
 Distribuzione geografica
Continente #
EU - Europa 345
NA - Nord America 343
AS - Asia 137
OC - Oceania 2
Totale 827
Nazione #
US - Stati Uniti d'America 343
GB - Regno Unito 152
CN - Cina 130
IE - Irlanda 56
SE - Svezia 43
FR - Francia 30
IT - Italia 27
DE - Germania 21
FI - Finlandia 6
UA - Ucraina 6
VN - Vietnam 3
AU - Australia 2
IR - Iran 2
RU - Federazione Russa 2
CH - Svizzera 1
IN - India 1
JP - Giappone 1
RO - Romania 1
Totale 827
Città #
Chandler 164
Southend 146
Dublin 56
Woodbridge 33
Houston 23
Ann Arbor 18
Jacksonville 18
Shenyang 18
Beijing 16
Jinan 15
Lawrence 14
Princeton 14
Nanjing 13
Verona 13
Wilmington 13
Tianjin 12
Ashburn 8
Guangzhou 7
Hebei 6
Ningbo 6
Siegen 6
Taizhou 5
Zhengzhou 5
Hangzhou 4
Nanchang 4
Augusta 3
Detroit 3
Lancaster 3
Redmond 3
Taiyuan 3
Changsha 2
Fuzhou 2
Haikou 2
London 2
Norwalk 2
Redwood City 2
Sossano 2
Adliswil 1
Ardabil 1
Austin 1
Bologna 1
Buffalo 1
Cascina 1
Cattolica 1
Des Moines 1
Dong Ket 1
Fairfield 1
Fremont 1
Kashan 1
Melbourne 1
Nürnberg 1
Phoenix 1
Riva 1
San Francisco 1
Sydney 1
Tokyo 1
Totale 685
Nome #
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 92
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 90
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 87
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 74
Tubulin inhibitors in non-small cell lung cancer: looking back and forward 73
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 72
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 61
A molecular signature associated with prolonged survival in glioblastoma patients treated with Regorafenib 54
Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system. 53
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that? 47
Do immune checkpoint inhibitors need new studies methodology? 46
Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies 46
Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study 28
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study 25
Totale 848
Categoria #
all - tutte 1590
article - articoli 1477
book - libri 0
conference - conferenze 113
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201865 0000 00 060 2210
2018/201966 27172 06 182 00210
2019/2020106 142011 1210 153 118317
2020/2021114 18111616 115 22 05217
2021/2022127 105421 121 16 22234
2022/2023297 16471499 2892 10 0000
Totale 848